Breaking News

Recipharm Reaches Agreement with LobSor Pharmaceuticals

Will manufacture Lecigon, a proprietary treatment for advanced Parkinson’s disease

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Recipharm and LobSor Pharmaceuticals, an Uppsala-based pharmaceutical company focusing on the development of systems to treat symptoms of advanced Parkinson’s disease (APD), have formed a manufacturing agreement for Lecigon. Recipharm will have exclusive manufacturing rights for volumes representing first three years of commercial sales. Recipharm will also support development costs against a mark-up on manufacturing prices, up to a certain volume, when Lecigon is produced for commercial sales. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters